INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 47m ago
HOUSE PTR7m ago
SEC 13F6m ago
ROBINHOOD CHAIN6m ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Feld Michael sold BDX

EVP, Chief Revenue Officer · BECTON DICKINSON & CO · Common Stock

Side
SELL
Value
$15K
Shares
76
Price
$198.13
Executed
Oct 26, 2026
Disclosed
Oct 27, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 26 executedOct 27, 2026 disclosed

BDX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
1/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+1 / 25

    $15K reported value · 0.4% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+4 / 15

    2 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BDX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    1
    FM
    Feld MichaelEVP, Chief Revenue Officer
    BDXBECTON DICKINSON & CO
    Open-market sale · 10b5-1 plan
    		SELL$14K
    76 sh
    		Sep 28, 2026Sep 29, 2026
    traded Sep 28, 2026
    		+1dSEC FORM 4

    Evidence

    5
    FM
    Feld MichaelEVP, Chief Revenue Officer
    BDXBECTON DICKINSON & CO
    Open-market sale · 10b5-1 plan
    		SELL$11K
    75 sh
    		Jun 26, 2026Jun 26, 2026
    traded Jun 26, 2026
    		+0dSEC FORM 4

    Evidence

    20
    Thomas H. Kean, Jr.RSelf
    BDXBECTON DICKINSON & CO
    Sale
    		SELL$1,001 – $15KMay 21, 2026Jun 18, 2026
    traded May 21, 2026
    		+28dHOUSE PTR

    Evidence

    24
    Kevin HernRJoint
    BDXBECTON DICKINSON & CO
    Sale
    		SELL$15K – $50KMar 17, 2026Apr 3, 2026
    traded Mar 17, 2026
    		+17dHOUSE PTR

    Evidence

    9
    SL
    Spikner Pamela L.SVP Controller & CAO
    BDXBECTON DICKINSON & CO
    Tax withholding
    		F—
    84 sh
    		Jan 21, 2026Jan 23, 2026
    traded Jan 21, 2026
    		+2dSEC FORM 4

    Evidence

    12
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Open-market sale · 10b5-1 plan
    		SELL$209K
    1,010 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    13
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Option exercise · 10b5-1 plan
    		M$513K
    3,054 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    13
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Disposition to issuer · 10b5-1 plan
    		D$513K
    2,454 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    8
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Open-market sale · 10b5-1 plan
    		SELL$125K
    600 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    0
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Option exercise · 10b5-1 plan
    		M—
    3,054 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SD
    Shan DavidEVP and Chief ISC Officer
    BDXBECTON DICKINSON & CO
    Tax withholding
    		F—
    44 sh
    		Jan 3, 2026Jan 6, 2026
    traded Jan 3, 2026
    		+3dSEC FORM 4

    Evidence

    21
    SL
    Scott Bertram LDirector
    BDXBECTON DICKINSON & CO
    Open-market sale
    		SELL$38K
    217 sh
    		Nov 7, 2025Nov 7, 2025
    traded Nov 7, 2025
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001628280-26-067525
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 26, 2026
    Published
    Oct 27, 2026
    Ingested by INSIDER
    Nov 5, 02:09 UTC
    Last re-read
    Nov 5, 02:09 UTC

    Extracted facts

    Filer
    Feld Michael
    Role
    EVP, Chief Revenue Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    BECTON DICKINSON & CO
    Ticker
    BDX
    Shares
    76
    Price per share
    $198.13
    Value
    $15,058
    Execution date (reported)
    Oct 26, 2026
    Owned after transaction
    19.6K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 76
    • Price: $198.13

    = $15,058

    What this establishes

    Feld Michael filed this Form 4 reporting a open-market sale of BDX on Oct 26, 2026. It became public on Oct 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP, Chief Revenue Officer
    Feld Michaelcik:0002034349
    Issuer
    BECTON DICKINSON & COcik:0000010795

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.